![]() Rosenberg received his Ph.D., from the Kellogg Pharmaceutical Clinical Scientist Program, University of Minnesota, College of Pharmacy and his Bachelor of Science, Pharmacy, from the Philadelphia College of Pharmacy and Science.Ĥ Quail Court, Mount Laurel, NJ 08054 (c: 60) He also currently serves as Head, Clinical Operations at Beat AML, LLC, a division of The Leukemia & Lymphoma Society. Rosenberg is Managing Partner of eP2Consulting, Inc. With his diverse background which includes executive management, clinical and regulatory operations, business development, eclinical technology solutions and new product/licensing evaluations, he brings tremendous hands on insights to optimizing the drug development cycle, from the early start-up stage to global product registration across many key therapeutic areas including CNS and oncology.ĭr. Rosenberg is a 30 plus year executive with proven experience in driving operational excellence at all levels within the pharmaceutical, biotechnology, eclinical and contract research organization sectors. Register your interest now to attend the event.ĭr. Join us for a two day event filled with case studies, panel discussion and face to face networking opportunities around clinical operations, technology and innovation, and data management. The conference will also be the platform for innovative case studies and break out discussions to connect and enhance your knowledge in the oncology space. The programme will take a holistic approach to the latest challenges and innovations in oncology operations such as end-user-CMO relationship during COVID-19, the evolvement of virtual trials and DTP in oncology trials along with regulatory updates in clinical trials. Dr.Discover effective strategies for oncology trial operations to ensure trials run smoothly and within budget.Īrena International is delighted to announce Clinical Operations in Oncology Trials East will take place in Boston in July 2023! The long-awaited event will offer clinical trial professionals from big and small pharma and biotechs in the oncology space a much-needed opportunity to uncover new technologies and processes to optimize their clinical and outsourcing operations. Buka’s medical practice focuses on conditions such as: acne, eczema and mole evaluations, while his cosmetic practice aims at reversing scars, spider veins, and signs of both photodamage and photoaging. Buka has two practice locations: Bobby Buka MD PC by the South Street Seaport in Downtown Manhattan, and Williamsburg Dermatology PC in Brooklyn. He is also on the advisory boards of both Skin & Aging Magazine and the Journal of Clinical, Cosmetic and Investigational dermatology.Ĭurrently Dr. His articles have been published in dermatology and plastic surgery textbooks as well as a number of medical research journals. He speaks at the annual meeting of the American Academy of Dermatology on topics ranging from complex eczema to techniques in dermatologic surgery. He is double board-certified by the American Academy of Dermatology and the Society for Pediatric Dermatology. Buka currently serves as the Section Chief at Mount Sinai School of Medicine. ![]() Buka also holds a law degree from Fordham University School of Law in New York City.ĭr. He then moved West to finish a dermatology residency at the University of California, San Diego and a fellowship in pediatric dermatology at Children’s Hospital in San Diego. Buka completed an internship in internal medicine at Saint Vincent’s Hospital in New York City. ![]() ![]() A graduate of the Feinberg School of Medicine at Northwestern University in Chicago, Dr. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |